Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Asthma, Exercise-Induced Bronchoconstriction
Interventions: Lyprinol, Placebo (Olive Oil); Dietary Supplement
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Preterm Birth, Child Development
Interventions: Docosahexaenoic Acid + Arachidonic Acid (DHA+AA), Placebo; Drug · Dietary Supplement
Lead sponsor: Sarah Keim; Other
Eligibility: 10 Months to 16 Months
Enrollment: 377 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Colorectal Adenomatous Polyps
Interventions: Eicosapentanoic acid and docosahexanoic acid, Oleic Acid; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 40 Years to 79 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction, Brain Injury, Depression - Major Depressive Disorder, Suicidal Ideation
Interventions: Magnetic e-Resonance Therapy (MeRT), Ibogaine Hydrochloride with Magnesium Sulfate, 5-methoxy-N,N-dimethyltryptamine, Physiological Supplementation; Device · Drug
Lead sponsor: Axial Therapeutic Research; Industry
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Northridge, California

Conditions: Myocardial Infarction, Death, Sudden, Cardiac
Interventions: Omega-3 Fatty Acids (Fish Oil Supplements), Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: ADHD
Interventions: Vayarin, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 60 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Cholestasis, Cholestasis of Parenteral Nutrition
Interventions: Omegaven; Drug
Lead sponsor: University of South Florida; Other
Eligibility: 14 Days and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Moderate Hypertriglyceridemia.
Interventions: Omega 3 fatty acid (Lovaza); Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: COVID-19
Interventions: Omega-3 (EPA+DHA), Placebo; Drug
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 18 Years to 89 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Edison, New Jersey

Conditions: Heart Health Markers, Cardiovascular Diseases, Omega 3 Fatty Acids
Interventions: Omega-3 Fatty Acids and Safflower Oil Placebo, Safflower Oil Placebo and Omega-3 Fatty Acids; Dietary Supplement
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 64 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Tucson, Arizona • Washington D.C., District of Columbia

Conditions: Type 1 Diabetes
Interventions: ORMD-0801 Treatment A, ORMD-0801 Treatment B, Placebo; Drug · Other
Lead sponsor: Oramed, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Tustin, California

Conditions: Diabetic Foot Ulcer
Interventions: Omeza® Complete Matrix, Standard of Care; Device · Other
Lead sponsor: Omeza, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 10
States / cities: Evergreen Park, Illinois • Denham Springs, Louisiana • Leesville, Louisiana + 7 more

Conditions: Coronary Artery Disease
Interventions: Omacor (omega-3-acid ethyl esters); Drug
Lead sponsor: Olive View-UCLA Education & Research Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Sylmar, California

Conditions: Pregnancy
Interventions: DHA, Placebo Capsule; Drug
Lead sponsor: Susan Carlson, PhD; Other
Eligibility: 16 Years to 35 Years · Female only
Enrollment: 190 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Healthy Subject
Interventions: Dietary Fiber, Fish Oil, Comparator; Dietary Supplement · Other
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 50 Years to 75 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Sarcopenia
Interventions: Omega-3 fatty acids, corn oil; Dietary Supplement
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 85 Years
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Traumatic Brain Injury
Interventions: Multivitamin Supplement intervention; Dietary Supplement
Lead sponsor: Amen Clinics, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Mania
Interventions: OMega 3, Placebo; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 10 Years to 21 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Alzheimer's Disease
Interventions: DHA (Docosahexaenoic Acid), Placebo; Drug
Lead sponsor: Alzheimer's Disease Cooperative Study (ADCS); Other
Eligibility: 50 Years and older
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 51
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 41 more

Conditions: PAD, Abdominal Aortic Aneurysm
Interventions: Pro-Omega, ProOmega Placebo; Dietary Supplement · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years to 90 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obesity, Heart Failure With Normal Ejection Fraction
Interventions: UFA dietary recommendations; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Dry Eye Syndrome
Interventions: Omega 3, Vitamins A, D3 and E; Dietary Supplement
Lead sponsor: Eye and Vision Technologies and Research Institute; Network
Eligibility: 18 Years to 79 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 4
States / cities: Conifer, Colorado • Oak Lawn, Illinois • Lexington, Kentucky + 1 more

Conditions: Atrial Fibrillation
Interventions: Omega Three Polyunsaturated fatty acids; Drug
Lead sponsor: Chirag Sandesara; Other
Eligibility: 18 Years to 85 Years
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Sickle Cell Disease
Interventions: SCD-Omegatex™; Drug
Lead sponsor: Robin E. Miller; Other
Eligibility: 8 Years to 25 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Wilmington, Delaware

Search by objective public record fields.

Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma

Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

Trifecta Research Study

Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging

Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment

Omegaven as Alternative Parenteral Fat Nutrition

Lovaza Mechanisms of Action

Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers

Omega-3D: Omega-3 for Diet-Driven Health Disparities

A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes

Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers

The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease

Kansas University DHA Outcome Study (KUDOS) Follow-Up

Fiber and Fish Oil Supplements for the Prevention of Colorectal Cancer

Fish Oil and Muscle Function

Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players

Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania

DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Obesity and HFpEF

Oral Nutrition Impact on Tear Film

Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery

Omega-3 Fatty Acids in Sickle Cell Disease